PlainRecalls
FDA Devices Moderate Class II Ongoing

Revaclear 300 dialyzers. Indicated for treatment of chronic and acute renal failure by hemodialysis.

Reported: December 28, 2022 Initiated: November 23, 2022 #Z-0762-2023

Product Description

Revaclear 300 dialyzers. Indicated for treatment of chronic and acute renal failure by hemodialysis.

Reason for Recall

Reports of Polyurethane Displacement in the dialyzer, and might be identified as a blood leak

Details

Units Affected
14,053,824 units
Distribution
Worldwide distribution - US Nationwide and the countries of Canada, China, Australia, New Zealand, Austria, Egypt, France, Germany, Ireland, Italy, Morocco, Qatar, Saudi Arabia, South Africa, Spain, United Kingdom, Bahamas, Barbados, Belize, Bermuda, Colombia, Dominican Republic, Ecuador, Guatemala, Honduras, Mexico, Panama, St. Thomas, Trinidad and Tobago.
Location
Deerfield, IL

Frequently Asked Questions

What product was recalled?
Revaclear 300 dialyzers. Indicated for treatment of chronic and acute renal failure by hemodialysis.. Recalled by Baxter Healthcare Corporation. Units affected: 14,053,824 units.
Why was this product recalled?
Reports of Polyurethane Displacement in the dialyzer, and might be identified as a blood leak
Which agency issued this recall?
This recall was issued by the FDA Devices on December 28, 2022. Severity: Moderate. Recall number: Z-0762-2023.